Article
"Let us not take ourselves too seriously. None of us has a monopoly on wisdom."
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Allotex appoints Michael Mrochen as CEO
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
NIH researchers use AI to enhance retinal imaging
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
ASCRS 2025: Companies share preview of data and presentations scheduled for 2025 annual meeting
Positive topline results from phase 2 VVN461 trial for non-infectious anterior uveitis